Regencell Bioscience Holdings Limited
RGC
Peringkat dalam Saham
#3444
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.10
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$5.01B
Perubahan (1 hari)
5.32%
Perubahan (1 tahun)
-40.45%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
EPS untuk Regencell Bioscience Holdings Limited (RGC)
EPS per June 2026 TTM: $-0.02
Menurut laporan keuangan terbaru dan harga saham Regencell Bioscience Holdings Limited, EPS perusahaan saat ini (TTM) adalah $-0.02. Pada akhir 2024, perusahaan memiliki EPS sebesar $-0.01 sama dengan EPS tahun 2023 sebesar $-0.01.
Riwayat EPS untuk Regencell Bioscience Holdings Limited dari 2019 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $-0.02 | 136.00% |
| 2025 | $-0.01 | -17.24% |
| 2024 | $-0.01 | -26.89% |
| 2023 | $-0.01 | -20.67% |
| 2022 | $-0.02 | 435.71% |
| 2021 | 0.00 | 64.71% |
| 2020 | 0.00 | 112.50% |
| 2019 | 0.00 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2,457.20% |
IN
|
